Tianda Pharmaceuticals Limited (SEHK: 455)
Health Care · Pharmaceuticals · HK
HK$0.12
+1.69% today · -18.9% 1Y
Tianda Pharmaceuticals Limited (SEHK: 455) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $32.88M.
Over the last twelve months the share price has lost 18.9%, trading between 0.08 and 0.14.
Tweenvest scores Tianda Pharmaceuticals Limited across four factors: quality 46/100, value 61/100, growth 0/100. Its strongest factor is value.
455 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $32.88M
- Revenue (TTM)
- $44.70M
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- -0.02
- 52-week high
- HK$0.14
- 52-week low
- HK$0.08
- Avg volume (3M)
- —
- Shares outstanding
- 2.15B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Prince Pharmaceutical Co., Ltd.TPEX: 6935 | $33.34M | NT$28.50 | +0.18% |
| Navamedic ASAOB: NAVA | $33.34M | Nkr13.30 | -0.37% |
| ImmuPharma plcAIM: IMM | $33.10M | £0.04 | +21.21% |
| biote Corp.NasdaqGM: BTMD | $32.98M | $1.12 | -2.61% |
| Syntara LimitedASX: SNT | $32.88M | AU$0.02 | +14.29% |
| Medical Developments International LimitedASX: MVP | $32.63M | AU$0.42 | -2.35% |
| Regent Pacific Group LimitedSEHK: 575 | $32.54M | HK$0.88 | +3.55% |
| PRISM BioLab Co.,LTDTSE: 206A | $32.45M | ¥139.00 | -4.79% |
Figures last refreshed Oct 11, 2026.